Back to Screener

Healthcare

Abcam plc(ABCM)

Live Price

Offline

$23.99

+0.04% today

1Y Change

—

Window

No data

Market Cap
$5.52B
Revenue Growth
-43.2%
EPS Growth
-135.3%
Dividend Yield
0.0%
No coverage

Historical coverage is still loading

We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.

No price data

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Abcam plc (ABCM) is a Healthcare stock with a market cap of $5.52B and listed on NASDAQ. The stock last traded around $23.99. Baseline metrics include revenue growth of -43.2%, EPS growth of -135.3%, a dividend yield of 0.0%. What stands out right now is revenue -43.2%, EPS -135.3%, free cash flow -118.5% with operating margin 2.0% and ROIC 0.6%. Valuation already assumes a fairly strong business story at P/E 578.4. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines ABCM price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

ABCM

—

Normalized return

SPY

—

S&P 500

Excess Return

—

Relative to SPY

ABCM Max Drawdown

—

Trailing 1Y

SPY Max Drawdown

—

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for ABCM and SPY.

Calendar-year return history is still loading or unavailable.

EPS Consensus

1.54

Range 1.54 → 1.54

No analyst count

vs prior: +14.8%

Revenue Outlook

$0.5B

Range $0.5B → $0.5B

No analyst count

vs prior: +10.0%

Consensus Spread

EPS spread0.0%
Revenue spread0.0%

Lower spread suggests tighter agreement across covering analysts.

Trend

EPS trend

Consensus average across visible periods

1.54
Latest visible period
Q2 2023Q3 2024
6 visible pointstrend: +14.8%

Trend

Revenue trend

Average analyst revenue estimate

$0.5B
Latest visible period
Q2 2023Q3 2024
6 visible pointstrend: +10.0%

Timeline

Analyst forecast ladder

Sorted by period end date. Includes both cached rows and live fallbacks from FMP.

Q3 2024
Ends Sep 30, 2024
quarter
Revenue
$0.5B
$0.5B to $0.5B
EPS
1.54
1.54 to 1.54
No analyst count
EPS: No analyst count
May 5, 11:56 AM UTC
stable/analyst-estimates
Q2 2024
Ends Jun 30, 2024
quarter
Revenue
$0.4B
$0.4B to $0.4B
EPS
1.34
1.34 to 1.34
No analyst count
EPS: No analyst count
May 5, 11:56 AM UTC
stable/analyst-estimates
Q1 2024
Ends Mar 30, 2024
quarter
Revenue
$0.4B
$0.4B to $0.4B
EPS
1.58
1.58 to 1.58
No analyst count
EPS: No analyst count
May 5, 11:56 AM UTC
stable/analyst-estimates
Q4 2023
Ends Dec 31, 2023
quarter
Revenue
$0.2B
$0.2B to $0.2B
EPS
0.25
0.25 to 0.25
No analyst count
EPS: No analyst count
May 5, 11:56 AM UTC
stable/analyst-estimates
Q3 2023
Ends Sep 30, 2023
quarter
Revenue
$0.3B
$0.3B to $0.3B
EPS
1.39
1.39 to 1.39
No analyst count
EPS: No analyst count
May 5, 11:56 AM UTC
stable/analyst-estimates
Q2 2023
Ends Jun 30, 2023
quarter
Revenue
$0.3B
$0.3B to $0.3B
EPS
1.19
1.19 to 1.19
No analyst count
EPS: No analyst count
May 5, 11:56 AM UTC
stable/analyst-estimates

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.

Read the analyst forecasts guideCompare stocks with this setup